The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Benzonatate 100 mg
Benzonatate 100 mg · BENZONATATE 100 mg/1 · Capsule, Liquid Filled · Oral · Marksans Pharma Limited
NDC 25000-0002-03 · 30 CAPSULE, LIQUID FILLED in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA220298
- TE code
- AA
- Approval date
- Mar 30, 2026
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Benzonatate 100 mg (Capsule, Liquid Filled)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Marksans Pharma Limited | BENZONATATE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Benzonatate 100 mg — NDC 25000-0002-03," retrieved September 3, 2026, https://drugdashboards.com/drug/25000000203.
Free to cite with attribution — see how the data is put together.